Bookmark and Share

Compound Summary for: CID 4449


Also known as: Nefazodona; Nefazodonum; Nefazodonum [Latin]; Nefazodona [Spanish]; 83366-66-9; UNII-59H4FCV1TF; Nefazodone (INN); CHEBI:7494
Molecular Formula: C25H32ClN5O2   Molecular Weight: 470.00688   InChIKey: VRBKIVRKKCLPHA-UHFFFAOYSA-N
Nefazodone hydrochloride (trade name Serzone) is an antidepressant drug marketed by Bristol-Myers Squibb. Its sale was discontinued in 2003 in some countries, due to the small possibility of hepatic (liver) injury, which could lead to the need for a liver transplant, or even death. The incidence of severe liver damage is approximately 1 in 250,000 to 300,000 patient-years. On May 20, 2004, Bristol-Myers Squibb discontinued the sale of Serzone in the United States. [Wikipedia]   From: DrugBank
Show subcontent titlesTable of Contents
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Biomolecular Interactions and Pathways
Biological Test Results
Chemical and Physical Properties
_ _